TY - JOUR
T1 - Effect of Short-Term Infusion of Sodium Nitroprusside on Mortality Rate in Acute Myocardial Infarction Complicated by Left Ventricular Failure
T2 - Results of a Veterans Administration Cooperative Study
AU - Cohn, Jay N.
AU - Franciosa, Joseph A.
AU - Francis, Gary S.
AU - Archibald, Donald
AU - Tristani, Felix
AU - Fletcher, Ross
AU - Montero, Alfredo
AU - Cintron, Guillermo
AU - Clarke, Janice
AU - Hager, David
AU - Saunders, Robert
AU - Cobb, Frederick
AU - Smith, Raphael
AU - Loeb, Henry
AU - Settle, Harold
PY - 1982/5/13
Y1 - 1982/5/13
N2 - Eight hundred twelve men with presumed acute myocardial infarction and left ventricular filling pressure of at least 12 mm Hg participated in a randomized double-blind placebo-controlled trial to assess the efficacy of a 48-hour infusion of sodium nitroprusside. The mortality rates at 21 days (10.4 per cent in the placebo group and 11.5 per cent in the nitroprusside group) and at 13 weeks (19.0 per cent and 17.0 per cent, respectively) were not significantly affected by treatment. The efficacy of nitroprusside was related to the time of treatment: the drug had a deleterious effect in patients whose infusions were started within nine hours of the onset of pain (mortality at 13 weeks, 24.2 per cent vs. 12.7 per cent; P = 0.025) and a beneficial effect in those whose infusions were begun later (mortality at 13 weeks, 14.4 per cent vs. 22.3 per cent; P = 0.04). Nitroprusside should probably not be used routinely in patients with high left ventricular filling pressures after acute myocardial infarction. However, the results in the patients given late treatment suggest that those with persistent pump failure might receive sustained benefit from short-term nitroprusside therapy. (N Engl J Med. 1982; 306:1129–35.) ACUTE myocardial infarction is frequently accompanied by global dysfunction of the left ventricle and continuing ischemia.1 2 3 In recent years recognition of the dynamic nature of this syndrome and the evidence that pharmacologic and physiologic manipulations can acutely alter the function and perfusion of the left ventricle4 5 6 has led to the hope that drug interventions can alter the natural history of the disease. Infusion of sodium nitroprusside, a potent arterial and venous dilator, has acutely improved left ventricular pump function in both experimental7,8 and clinical9 10 11 myocardial infarction by raising cardiac output and reducing filling pressure. The salutary clinical and hemodynamic response.
AB - Eight hundred twelve men with presumed acute myocardial infarction and left ventricular filling pressure of at least 12 mm Hg participated in a randomized double-blind placebo-controlled trial to assess the efficacy of a 48-hour infusion of sodium nitroprusside. The mortality rates at 21 days (10.4 per cent in the placebo group and 11.5 per cent in the nitroprusside group) and at 13 weeks (19.0 per cent and 17.0 per cent, respectively) were not significantly affected by treatment. The efficacy of nitroprusside was related to the time of treatment: the drug had a deleterious effect in patients whose infusions were started within nine hours of the onset of pain (mortality at 13 weeks, 24.2 per cent vs. 12.7 per cent; P = 0.025) and a beneficial effect in those whose infusions were begun later (mortality at 13 weeks, 14.4 per cent vs. 22.3 per cent; P = 0.04). Nitroprusside should probably not be used routinely in patients with high left ventricular filling pressures after acute myocardial infarction. However, the results in the patients given late treatment suggest that those with persistent pump failure might receive sustained benefit from short-term nitroprusside therapy. (N Engl J Med. 1982; 306:1129–35.) ACUTE myocardial infarction is frequently accompanied by global dysfunction of the left ventricle and continuing ischemia.1 2 3 In recent years recognition of the dynamic nature of this syndrome and the evidence that pharmacologic and physiologic manipulations can acutely alter the function and perfusion of the left ventricle4 5 6 has led to the hope that drug interventions can alter the natural history of the disease. Infusion of sodium nitroprusside, a potent arterial and venous dilator, has acutely improved left ventricular pump function in both experimental7,8 and clinical9 10 11 myocardial infarction by raising cardiac output and reducing filling pressure. The salutary clinical and hemodynamic response.
UR - http://www.scopus.com/inward/record.url?scp=0020026722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020026722&partnerID=8YFLogxK
U2 - 10.1056/NEJM198205133061902
DO - 10.1056/NEJM198205133061902
M3 - Article
C2 - 7040956
AN - SCOPUS:0020026722
SN - 0028-4793
VL - 306
SP - 1129
EP - 1135
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 19
ER -